BBP Holdings
Virtus Biotech ETF
1W: -2.2%
1M: -6.7%
3M: +3.1%
YTD: +28.5%
1Y: +44.2%
3Y: +100.6%
5Y: +96.4%
$102.36
-0.85 (-0.82%)
Weekly Expected Move ±3.5%
$95
$99
$102
$106
$109
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$42M
Holdings65
Top 10 Wt26.8%
Beta0.84
% Profitable46%
Coverage100%
Portfolio Valuation
P/E47.1
P/B7.0
P/S7.8
EV/EBITDA31.2
P/FCF29.3
PEG2.27
Profitability & Returns
Gross Margin76.6%
Net Margin1.1%
ROE1.0%
ROA0.5%
ROIC4.8%
Div Yield0.08%
Leverage & Liquidity
Debt/Equity0.68
Debt/Assets0.32
Net Debt/EBITDA0.4x
Interest Cov2.0x
Current Ratio2.44
Quick Ratio2.15
Growth (YoY)
Revenue+47.0%
Net Income+30.2%
EPS+33.1%
FCF+47.7%
EBITDA+33.6%
Rev CAGR 3Y+111.6%
Quality Scores
Piotroski F4.6
Altman Z6.43
IS Quality52.5
IS Overall46.5
IS Value40.0
Median P/E-5.7
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 65 | 99.8% | -4.8 |
| Other | 2 | 0.2% | — |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 67 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 5.17% | $6.9M | 33,770 | -23.8 | $75.4B | Healthcare |
| 2 | Iovance Biotherapeutics Inc | IOVA | 4.49% | $6.0M | 413,111 | -20.3 | $6.3B | Healthcare |
| 3 | Omeros Corp | OMER | 2.80% | $3.7M | 192,959 | 9.7 | $1.3B | Healthcare |
| 4 | Verastem Inc | VSTM | 2.45% | $3.3M | 411,097 | -3.1 | $677M | Healthcare |
| 5 | Precigen Inc | PGEN | 2.30% | $3.0M | 378,763 | -7.5 | $3.0B | Healthcare |
| 6 | Halozyme Therapeutics Inc | HALO | 2.04% | $2.7M | 24,252 | 31.2 | $13.0B | Healthcare |
| 7 | Zai Lab Ltd | ZLAB | 1.93% | $2.6M | 98,741 | -14.4 | $2.7B | Healthcare |
| 8 | Rigel Pharmaceuticals Inc | RIGL | 1.89% | $2.5M | 51,309 | 2.7 | $872M | Healthcare |
| 9 | Xeris Biopharma Holdings Inc | XERS | 1.87% | $2.5M | 248,233 | -93.5 | $1.6B | Healthcare |
| 10 | Kiniksa Pharmaceuticals International Plc | KNSA | 1.85% | $2.5M | 32,483 | 70.8 | $5.8B | Healthcare |
| 11 | BeOne Medicines Ltd | BGNE | 1.75% | $2.3M | 6,373 | 3.6 | $20.2B | Healthcare |
| 12 | Protagonist Therapeutics Inc | PTGX | 1.63% | $2.2M | 15,354 | 115.0 | $9.0B | Healthcare |
| 13 | ImmunityBio Inc | IBRX | 1.58% | $2.1M | 237,394 | -10.6 | $10.8B | Healthcare |
| 14 | Tarsus Pharmaceuticals Inc | TARS | 1.57% | $2.1M | 27,207 | -67.0 | $3.1B | Healthcare |
| 15 | Regeneron Pharmaceuticals Inc | REGN | 1.56% | $2.1M | 2,753 | 17.6 | $75.7B | Healthcare |
| 16 | Sarepta Therapeutics Inc | SRPT | 1.55% | $2.1M | 110,091 | -12.2 | $1.8B | Healthcare |
| 17 | Novavax Inc | NVAX | 1.55% | $2.1M | 189,808 | -6.9 | $1.7B | Healthcare |
| 18 | Ligand Pharmaceuticals Inc | LGND | 1.54% | $2.0M | 6,595 | 30.3 | $6.1B | Healthcare |
| 19 | ADMA Biologics Inc | ADMA | 1.54% | $2.0M | 205,298 | 13.5 | $2.3B | Healthcare |
| 20 | Roivant Sciences Ltd | ROIV | 1.54% | $2.0M | 56,108 | -94.0 | $25.8B | Healthcare |
| 21 | Gilead Sciences Inc | GILD | 1.53% | $2.0M | 13,420 | -55.7 | $179.5B | Healthcare |
| 22 | Kura Oncology Inc | KURA | 1.52% | $2.0M | 186,243 | -3.2 | $945M | Healthcare |
| 23 | Amgen Inc | AMGN | 1.51% | $2.0M | 4,745 | 24.8 | $217.5B | Healthcare |
| 24 | Zymeworks Inc | ZYME | 1.51% | $2.0M | 73,667 | -12.5 | $1.9B | Healthcare |
| 25 | Vertex Pharmaceuticals Inc | VRTX | 1.50% | $2.0M | 3,788 | 29.1 | $128.1B | Healthcare |
| 26 | Insmed Inc | INSM | 1.50% | $2.0M | 17,226 | -27.0 | $24.1B | Healthcare |
| 27 | Travere Therapeutics Inc | TVTX | 1.46% | $1.9M | 32,389 | -126.5 | $5.3B | Healthcare |
| 28 | Harmony Biosciences Holdings Inc | HRMY | 1.45% | $1.9M | 48,911 | 12.7 | $2.3B | Healthcare |
| 29 | Ironwood Pharmaceuticals Inc | IRWD | 1.45% | $1.9M | 461,779 | 4.6 | $599M | Healthcare |
| 30 | Nuvation Bio Inc | NUVB | 1.45% | $1.9M | 342,580 | -11.8 | $1.8B | Healthcare |
| 31 | TG Therapeutics Inc | TGTX | 1.44% | $1.9M | 34,037 | 17.8 | $8.3B | Healthcare |
| 32 | Biogen Inc | BIIB | 1.44% | $1.9M | 8,426 | 38.7 | $32.5B | Healthcare |
| 33 | Incyte Corp | INCY | 1.44% | $1.9M | 15,530 | 14.2 | $23.4B | Healthcare |
| 34 | CRISPR Therapeutics AG | CRSP | 1.43% | $1.9M | 33,845 | -11.6 | $5.3B | Healthcare |
| 35 | Agios Pharmaceuticals Inc | AGIO | 1.43% | $1.9M | 57,213 | -4.5 | $1.9B | Healthcare |
| 36 | Exelixis Inc | EXEL | 1.40% | $1.9M | 31,724 | 17.7 | $14.7B | Healthcare |
| 37 | Arcutis Biotherapeutics Inc | ARQT | 1.39% | $1.8M | 69,134 | 113.9 | $3.1B | Healthcare |
| 38 | BioNTech SE | BNTX | 1.38% | $1.8M | 18,616 | -12.7 | $24.3B | Healthcare |
| 39 | Rhythm Pharmaceuticals Inc | RYTM | 1.37% | $1.8M | 19,071 | -29.8 | $6.4B | Healthcare |
| 40 | Geron Corp | GERN | 1.37% | $1.8M | 1,465,648 | -12.0 | $770M | Healthcare |
| 41 | BioMarin Pharmaceutical Inc | BMRN | 1.36% | $1.8M | 30,125 | 150.5 | $11.1B | Healthcare |
| 42 | Immunocore Holdings PLC | IMCR | 1.35% | $1.8M | 58,201 | -164.8 | $1.5B | Healthcare |
| 43 | Krystal Biotech Inc | KRYS | 1.34% | $1.8M | 5,301 | 39.0 | $9.5B | Healthcare |
| 44 | Madrigal Pharmaceuticals Inc | MDGL | 1.34% | $1.8M | 3,506 | -38.7 | $11.5B | Healthcare |
| 45 | Ascendis Pharma A/S | ASND | 1.33% | $1.8M | 7,730 | 16.7 | $14.2B | Healthcare |
| 46 | Aurinia Pharmaceuticals Inc | AUPH | 1.32% | $1.7M | 106,543 | 6.7 | $2.0B | Healthcare |
| 47 | Syndax Pharmaceuticals Inc | SNDX | 1.27% | $1.7M | 92,356 | -7.0 | $1.6B | Healthcare |
| 48 | Liquidia Corp | LQDA | 1.26% | $1.7M | 23,663 | 18.3 | $2.5B | Healthcare |
| 49 | Bridgebio Pharma Inc | BBIO | 1.25% | $1.7M | 25,232 | -18.8 | $13.2B | Healthcare |
| 50 | ACADIA Pharmaceuticals Inc | ACAD | 1.22% | $1.6M | 79,919 | 8.9 | $3.4B | Healthcare |